PAPP-A, IGFBP-4, and IGFBP-4 proteolytic fragments play a crucial role in the pathogenesis of CVDs, including coronary heart disease, acute coronary syndrome, and acute heart failure [18,19,20]. Here, IGFBP4 is linked to coronary artery disorder.